We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

PURITAN MEDICAL

Puritan Medical Products is a manufacturer of healthcare, diagnostic and critical environment products. Its portfolio... read more Featured Products: More products

Download Mobile App





Puritan Medical Opening New Facility to Double COVID-19 Swab Production

By LabMedica International staff writers
Posted on 10 Jun 2020
Print article
Image: Puritan Medical Opening New Facility to Double COVID-19 Swab Production (Photo courtesy of Puritan Medical Products)
Image: Puritan Medical Opening New Facility to Double COVID-19 Swab Production (Photo courtesy of Puritan Medical Products)
Puritan Medical Products (Guilford, ME, USA) is opening a new facility that will allow the company to produce an additional 20 to 40 million swabs per month in order to fulfill the need for COVID-19 testing swabs in the US.

Puritan is a manufacturer of single-use products for controlled environments, diagnostics and specimen collection, environmental, forensics, and genetics, medical and microbiology media industries. As a FDA-registered and ISO-certified company, Puritan manufactures products, including patented flock swabs, that help customers collect, analyze and transport specimens.

Puritan’s new production facility will be located in the company’s 95,000 square foot building in Pittsfield, ME. The new top-of-the-line medical device manufacturing space will include a Class 7 cleanroom where the swabs will be made. Puritan and its subcontractors are working around the clock to complete the new facility, and the company expects to begin producing swabs at its second plant by July 1, 2020.

“We are committed to providing products and resources to help in this critical effort to stop the spread of COVID-19. Together with our construction and manufacturing partners and our dedicated employees, we are ready and able to increase production to meet our national public health needs,” said Timothy Templet, Executive Vice President of Global Sales for Puritan Medical Products.

Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Dermatophytosis Rapid Diagnostic Kit
StrongStep Dermatophytosis Diagnostic Kit
New
Centrifuge
Hematocrit Centrifuge 7511M4

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.